Hüseyin Örün

Dr. Hüseyin Örün

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 May 2022 in Intractable & Rare Diseases Research
Verified
Journal Article
Closed access
PDF file
ÇFÇağlar Fidan
Çağlar Fidan
HÖHüseyin Örün
Hüseyin Örün
AAAslı Begüm Alper
Aslı Begüm Alper
ÇÜÇiğdem Naz Ünver
Çiğdem Naz Ünver
ÖŞÖmer Can Şahin
Ömer Can Şahin
DTDomenica Taruscio
Domenica Taruscio
Bloodspot screening in newborns is an exemplary public health intervention as it is essential secondary prevention with proven efficacy and benefit for the early diagnosis and prompt treatment of rare diseases. In this mini review, newborn bloodspot screening (NBS) programs of 12 countries were examined in terms of the extent of diseases/disorders screened to form recommendations for Turkey's expanded newborn screening program. Essentially, Turkey and 11 selected countries' official policies/national programs or strategies in terms of newborn screening and the number of diseases/conditions screened were examined. The current status of spinal muscular atrophy (SMA) screening was also checked through the SMA NBS Alliance. In addition, WHO and EURORDIS guidelines for newborn screening were also reviewed. On the Pubmed database, following the search strategy "((newborn screening[Title/Abstract]) OR (newborn screening program[Title/Abstract])) OR (newborn blood spot screening[Title/Abstract])" in the PubMed database from 1 January 2008 to 1 December 2021. Diseases that will be recommended to be included in the Turkish national newborn bloodspot screening program will be presented by evaluating the updated criteria of Wilson and Jungner by constructing international comparisons. The number of diseases/disorders screened by the inspected 12 countries is eminently variable and ranges from 5 in Turkey to 51 in New York, United States of America (USA). Acknowledging the programs of other countries, it is evident that Turkey must advance its program by evaluating the epidemiological data in Turkey, the health workforce, and infrastructure while relying on the updated screening criteria. The newborn bloodspot screening program should be expanded based on the cost estimates and implemented starting with pilot applications and the diseases/disorders that are deemed appropriate should be included in the national program.

16 April 2019 in Iranian Journal of Allergy, Asthma and Immunology
Verified
Journal Article
Open access
PDF file
ECEmel Ceylan
Emel Ceylan
SBSertan Bulut
Sertan Bulut
MYMustafa Yılmaz
Mustafa Yılmaz
HÖHüseyin Örün
Hüseyin Örün
FKFisun Karadağ
Fisun Karadağ
AKAslıhan Karul
Aslıhan Karul
The effects of comorbidities on systemic inflammation markers in stable asthmatics and the consequences of such effects have not been well evaluated. We aimed to evaluate the effect of comorbidities on clinical manifestations and systemic inflammation in asthmatic patients under control. The study group consisted of asthmatic patients who applied to our pulmonology outpatient clinic and volunteered to participate. 120 clinically stable asthma patients (71 females and 49 males) and 35 healthy controls (19 females and 16 males) with similar age, gender, and body mass index distributions were admitted to the study. The levels of osteopontin, interleukin 6 (IL-6), interleukin 8 (IL-8), interleukin 13 (IL-13), eosinophilic cationic protein, adiponectin, and high-sensitivity C-reactive protein of the individuals were evaluated using commercial ELISA kits by taking venous blood samples. Of 120 asthmatic subjects, 47 (39,2%) had comorbidities and allergic rhinitis (15%) coexisted most frequently. Other comorbidities associated with asthma were gastroesophageal reflux, sinusitis, hypertension, diabetes, gastritis, and peptic ulcus respectively. There was no physician-diagnosed comorbidity in the control group. The levels of IL-6 and IL-8 were found higher in asthma group with comorbidities when compared to those with no comorbidities (p values were 0.032 and 0.046, respectively). Comorbidities interfere with the diagnosis and treatment of asthma, besides affecting the disease control. Our findings suggest the possibility of the impact of comorbidities on systemic inflammation markers, especially IL-6 and IL-8. To evaluate the impact of comorbidities on asthma control and systemic markers, further studies are needed.

1 September 2025 in International Journal of General Medicine
Verified
Journal Article
Open access
PDF file
SDSibel Doruk
Sibel Doruk
GKGülistan Karadeniz
Gülistan Karadeniz
HÖHüseyin Örün
Hüseyin Örün
SDSami Deniz
Sami Deniz
GPGülru Polat
Gülru Polat
Purpose: Platelet-Lymphocyte Ratio (PLR) and Neutrophil-Lymphocyte Ratio (NLR) are the parameters investigated in acute pulmonary thromboembolism (aPTE) mortality. This study aimed to determine the prognostic value of NLR, PLR, and other parameters in aPTE. A retrospective cohort study was conducted in a Research and Training Hospital. Patients and Methods: The study included 346 aPTE cases, and mortality at the first week, first month, and sixth month were determined as endpoints. The medical files of the cases were examined. Age, sex, date of diagnosis, vital status, the last follow-up date, hemogram, lower extremity venous Doppler ultrasonography, and intensive care unit admissions were recorded. Cox regression analysis was performed to identify prognostic factors associated with mortality, and hazard ratio (HR) and a 95% confidence interval (CI) were reported. Results: Median follow-up was 898.5 days. There was no significant difference in terms of sex on mortality. The deceased cases in the 1st month and 6th month were older than the survivors; among them, intensive care unit (ICU) admission rates were higher, and deep venous thrombosis (DVT) was less frequently detected. In the first week, ICU admission rates were higher in deceased cases, and DVT was determined less frequently among them. NLR was higher in all deceased patients, while PLR was elevated in deceased cases in the first and 6th months. ICU admission and DVT status were consistently associated with mortality across all three time points. NLR was identified as a good prognostic factor for the first month of mortality (95% CI: 1.017– 1.168 HR: 1.090). PLR and age were poor prognostic factors; PLR was positively associated with 6th-month survival (95% CI: 1.001– 1.005 HR: 1.003). Conclusion: NLR is a good prognostic factor, and PLR and age are poor prognostic factors. DVT may help in early diagnosis, which may be associated with lower mortality.

15 September 2018 in European Respiratory Journal
Verified
Conference Paper
Closed access
ECEmel Ceylan
Emel Ceylan
HÖHüseyin Örün
Hüseyin Örün
TGTuğçe Kübra Güleç
Tuğçe Kübra Güleç
MAMert Altaş
Mert Altaş
NENuray Seyitoğlu Ertek
Nuray Seyitoğlu Ertek
FKFisun Karadağ
Fisun Karadağ
Aim: Inhalation therapy is essential for management of chronic obstructive lung diseases (COLD). Non-adherence to treatment regime and inadequate inhaler technique are important causes of therapy failure. This study was aimed to evaluate adherence rate to inhaler treatments and factors affecting critical errors of inhaler technique. Material and Methods: A questionnaire was applied to the patients with COLD within the scheduled time period. Treatment adherence and the inhaler technique were assessed by Test of the Adherende to Inhalers(TAI) Questionnaire. Cognitive status was evaluated by Mini-Mental State Examination (MMSE). Patients≥65 years old were grouped as elderly whereas <65 were grouped as non-elderly. Results: 135 patients (69 asthmatics and 66 COPD patients) were recruited to the study. The elderly group consisted of 54 patients and non-elderly group had 81 patients. Although the score of MMSE was found lower in the elderly, rate of cognitive impairment was similar between the groups. The adherence score according to TAI-10 was found higher in the elderly (median 49 versus 47, p=0,004). There was higher good adherence rate in the elderly (37% versus 18.5%, p=0,016).TAI-10 score was higher in COPD patients than asthmatics (median 48 versus 46 respectively, p=0,006). Seventy patients (51.9%) made critical errors when using their inhalers. Elderly group and COPD patients made more critical errors (p=0,005 and p=0,02). No difference was found in critical errors according to type of the inhaler device. Conclusion: Adherence rate was higher in the elderly, but they made more critical errors when using inhalers. COPD patients also made more mistakes than asthmatics.

18 December 2025 in Journal of Cancer Policy
Verified
Journal Article
Closed access
HÖHüseyin Örün
Hüseyin Örün
HPHilal Polat
Hilal Polat

27 September 2022 in Meandros Medical and Dental Journal
Verified
Journal Article
Closed access
NANihal Bilgili Aykut
Nihal Bilgili Aykut
HÖHüseyin Örün
Hüseyin Örün
ETEcenur Topal
Ecenur Topal